Tg Therapeutics (TGTX) Net Income (2009 - 2026)
Tg Therapeutics (TGTX) posted Net Income of $7.73 million for Q2 2026, down 72.6% from $28.19 million a year earlier and down 60.9% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Net Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income at Tg Therapeutics was $441.44 million, up 630.2% year-over-year; for FY2025, it was $447.18 million.
- In prior years, Tg Therapeutics' Net Income was $23.38 million in FY2024 (+84.5%), $12.67 million in FY2023, -$198.34 million in FY2022 and -$348.1 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Net Income since Q1 2025.
- On a year-over-year basis, Net Income increased in two of the last five quarters, with growth averaging 86.0%.
- According to Business Quant data, Net Income for the three prior quarters was $19.76 million (Q1 2026), $23.04 million (Q4 2025) and $390.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Tg Therapeutics | 9.71 Bn | 8.96 Bn | 217.86 Mn | 55.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.46 Mn |
| Jun 30, 2026 | 7.78 Mn |
| Mar 31, 2026 | 19.78 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 390.90 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Dec 31, 2023 | -14.42 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | -47.61 Mn |
| Mar 31, 2023 | -39.23 Mn |
| Dec 31, 2022 | -78.47 Mn |
| Sep 30, 2022 | -35.82 Mn |
| Jun 30, 2022 | -40.51 Mn |
| Mar 31, 2022 | -69.01 Mn |
| Dec 31, 2021 | -93.34 Mn |
API Access
Tg Therapeutics Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();